OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP. Share Price

Certificat

DE000GG2D9S6

Market Closed - BOERSE MUENCHEN 11:56:43 14/06/2024 pm IST
3.28 EUR +0.31% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP.
Current month+8.97%
1 month+95.24%
Date Price Change
14/24/14 3.28 +0.31%
13/24/13 3.27 -11.86%
12/24/12 3.71 +5.10%
11/24/11 3.53 -3.29%
10/24/10 3.65 -7.83%

Real-time BOERSE MUENCHEN

Last update June 14, 2024 at 11:56 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GG2D9S
ISINDE000GG2D9S6
Date issued 10/01/2024
Strike 308.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.77
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.45
Lowest since issue 1.21
Spread 0.07
Spread %1.99%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
345 USD
Average target price
372.5 USD
Spread / Average Target
+7.98%
Consensus